Not finding it? Sign in to also search OpenAlex live.
-
Inhaler use and their carbon footprint in Germany: a 10-year analysis (2013–2022)2025 BMJ Open Respiratory Research article Environmental Science Environmental Impact and Sustainability Open access
Sarah Blau, Martin Mücke, Michaela Hesse, Julia Sellin, Gabriele Gradl, Martin Schulz, +1 more
0citations -
Efficacy and Safety of Less Frequent/Lower Intensity Dosing of Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study
Ajai Chari, Albert Oriol, Amrita Y. Krishnan, Maria Del Carmen Martinez Chamorro, Luciano J. Costa, María‐Victoria Mateos, +9 more
50citations -
Safety, tolerability and pharmacokinetic characterisation of DACRA KBP‐042 in healthy male subjects2021 British Journal of Clinical Pharmacology article Medicine Diabetes Treatment and Management Open access
Kim Henriksen, Karen Broekhuizen, Wadim M. I. de Boon, M.A. Karsdal, Asger Reinstrup Bihlet, Claus Christiansen, +5 more
16citations -
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study2025 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Michiel M. Smeenk, Vincent van der Noort, Jeroen J. M. A. Hendrikx, Hanieh Abedian Kalkhoran, Egbert Frederik Smit, Willemijn S.M.E. Theelen
13citations -
Critical appraisal of evidence for anti-Xa monitoring and dosing of low-molecular-weight heparin in renal insufficiency2022 Expert Review of Clinical Pharmacology article Medicine Venous Thromboembolism Diagnosis and Management Open access
Marcel P. H. van den Broek, Marjon V. Verschueren, Catherijne A. J. Knibbe
15citations -
Model-informed development of a cost-saving dosing regimen for enfortumab vedotin2025 Cancer Chemotherapy and Pharmacology article Medicine Pharmaceutical studies and practices Open access
Amy Rieborn, Dirk Jan A. R. Moes, Jeroen J. M. A. Hendrikx, Michiel S. van der Heijden, Mira D. Franken, Tom van der Hulle, +5 more
5citations -
Algorithm-managed dosing and pharmacist-managed dosing of erythropoietin stimulating agents in renal anaemia: a systematic review2025 European Journal of Hospital Pharmacy review Medicine Erythropoietin and Anemia Treatment Open access
Francisca Johanna van den Oever, Marijke J.E. Dekker, Erwin C. Vasbinder, Teun van Gelder, Patricia M. L. A. van den Bemt
0citations -
Acido bempedoico nella pratica clinica reale: dati basali e a 8 settimane dallo studio prospettico non interventistico italiano MILOS2026 Giornale italiano di cardiologia article Medicine Lipoproteins and Cardiovascular Health Open access
Antonina Giammanco, Rosanna Gambacurta, Ioanna Gouni‐Berthold, J. Wouter Jukema, J R Van Lennep, Kausik Kumar Ray, +11 more
0citations -
Development of a Quasi–Quantitative Structure–Activity Relationship Model for Prediction of the Immobilization Response of Daphnia magna Exposed to Metal-Based Nanomaterials2022 Environmental Toxicology and Chemistry article Environmental Science Environmental Toxicology and Ecotoxicology Open access
Warisa Bunmahotama, Martina G. Vijver, Willie J.G.M. Peijnenburg
11citations -
Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo‐Controlled, Parallel Group, First‐In‐Human Study in Healthy Male Participants
Marella C. E. van Ruissen, Sebastiaan J. W. van Kraaij, Jana Wolfova, Yanick Botilde, Lutz Wollin, Naomi B. Klarenbeek
5citations -
Adverse events and their management in patients with tenosynovial giant cell tumor (TGCT) treated with pimicotinib, after longer-term follow-up from the global phase 3 MANEUVER trial.2026 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access
Vinod Ravi, Vishal Ghori, Aimar Zhang, Niki Karachaliou, Hans A. J. Gelderblom, Qingping Zou, +2 more
0citations -
Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time2020 European Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access cited by 1 patent
Emma C. Hulshof, Maarten J. Deenen, Henk‐Jan Guchelaar, Hans A. J. Gelderblom
53citations -
Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor2021 CPT Pharmacometrics & Systems Pharmacology article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Ophelia Q. P. Yin, Hamim Zahir, Jonathan French, Daniel G. Polhamus, Xiaoning Wang, Michiel A. J. van de Sande, +6 more
10citations